Hypertension, or high blood pressure, is a common health condition that affects millions of people in Europe and around the world. It is a major risk factor for many serious health conditions, including stroke, heart attack, and kidney disease. Hypertension is also a major contributor to the burden of disease in Europe, with an estimated 2 million deaths attributable to hypertension each year. This article will explore the impact of hypertension on European society, focusing on the prevalence, risk factors, and health outcomes associated with the condition.
Hypertension is a major public health issue in Europe, with an estimated 45 million people affected by the condition. Hypertension is more common in older age groups, with the highest prevalence among those aged 65 and over. Hypertension is also more common in men than women, and in those living in lower socioeconomic groups.
The risk factors for hypertension are well-established and include lifestyle factors such as smoking, physical inactivity, and poor diet. Other risk factors include age, family history, and certain medical conditions such as diabetes and kidney disease.
Hypertension is a major risk factor for a range of serious health conditions, including stroke, heart attack, and kidney disease. Hypertension can also lead to an increased risk of cognitive decline, dementia, and depression. Hypertension is also associated with an increased risk of death, with an estimated 2 million deaths attributable to hypertension each year in Europe.
The impact of hypertension on European society is significant, with the condition leading to an increased burden of disease, increased health care costs, and reduced quality of life. Hypertension is also associated with an increased risk of disability, with an estimated 10 million people in Europe living with a disability caused by hypertension.
The prevention and management of hypertension is essential in order to reduce the burden of the condition on European society. Lifestyle modification is the cornerstone of hypertension management, with a focus on smoking cessation, physical activity, and healthy eating. Other management strategies include the use of medications, such as ACE inhibitors, beta-blockers, and diuretics.
Hypertension is a major public health issue in Europe, with an estimated 45 million people affected by the condition. The impact of hypertension on European society is significant, with the condition leading to an increased burden of disease, increased health care costs, and reduced quality of life. The prevention and management of hypertension is essential in order to reduce the burden of the condition on European society. Lifestyle modification is the cornerstone of hypertension management, with a focus on smoking cessation, physical activity, and healthy eating. Other management strategies include the use of medications, such as ACE inhibitors, beta-blockers, and diuretics.
1.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
2.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
3.
In early dementia, SSRIs enhance cognition and major depression.
4.
Breast Cancer Incidence Increased Due to Particulate Air Pollution, According to NIH Study.
5.
Mouse study finds tirzepatide slowed obesity-associated breast cancer growth
1.
Bispecific Antibodies in Hematologic Malignancies: Mechanisms, Clinical Applications, and Future Directions
2.
Teaching Oncologic Emergencies Through Priority-Based Learning
3.
Understanding Protein C Deficiency: Symptoms, Causes, and Treatment
4.
The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies
5.
Emicizumab in Infants with Severe Hemophilia A: HAVEN 7 Phase 3b Trial Insights
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
How Advances in Cancer Research Are Improving Treatment Options
2.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
4.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation